Damon Runyon Funds High-Risk Cancer Studies | GenomeWeb

NEW YORK (GenomeWeb News) – The Damon Runyon Cancer Research Foundation has awarded three grants totaling more than $1.3 million to researchers pursuing high-risk cancer research involving genomics, proteomics, and metabolomics, the foundation said today.

The 2010 Damon Runyon-Rachleff Innovation Awards will give three investigators grants of $450,000, to be spread out over three years at $150,000 per year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.